Notice of FY2024 Cohort Dates for PAR-22-073, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
Notice Number:
NOT-OD-23-188

Key Dates

Release Date:

September 26, 2023

Related Announcements

  • August 2, 2022 -  Notice of FY2023 Cohort Dates for PAR-22-073, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed). See Notice NOT-CA-22-116.
  • November 19, 2021 - Innovation Corps (I-Corps?) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed). See NOFO PAR-22-073

Issued by

Office of The Director, National Institutes of Health (OD)

Purpose

This Notice is to inform potential applicants that the following cohort dates are scheduled in FY2024 for PAR-22-073, “Innovation Corps (I-CorpsTM) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed).” This notice also informs all potential applicants that the kick-off sessions of each cohort will be held in person at locations to be announced later. Close-out sessions will be held at facilities near the NIH campus in Bethesda Maryland. All other workshops will be conducted virtually.

Please note that the third cohort in FY2024 (July 8– August 21) is restricted to early-stage Phase I SBIR/STTR projects awarded by the National Cancer Institute (NCI) under the  Small Business Transition Grant and Concept Award
 

The following changes and updates are made to PAR-22-073 (shown in italics) to reflect cohort dates and venues for the cohorts of FY2024.

Part 1. Overview Information, Key Dates

Currently Reads:

Application Due Date(s): December 15, 2021; February 2, 2022; November 15, 2022; February 2, 2023; November 15, 2023; February 2, 2024 by 5:00 PM local time of applicant organization.

Expiration Date: February 3, 2024


Modified to read (in italics):

Application Due Date(s): December 15, 2021; February 2, 2022; November 15, 2022; February 2, 2023; November 15, 2023; January 31, 2024; April 30, 2024 by 5:00 PM local time of applicant organization.

Expiration Date: May 1, 2024


Part 2. Full Text of Announcement, Section I. Funding Opportunity Description

Currently Reads:

Details for the FY2023 cohorts are given below. All team members accepted to the I-Corps at NIH are required to participate in each of the program events given below. Additional dates will be released by Notice.

Modified to read (in italics):

Details for the FY2024 cohorts are given below. All team members accepted to the I-Corps at NIH are required to participate in each of the program events given below.

 Cohort 1Cohort 2Cohort 3 NCI Only
Application Due DateNovember 15, 2023January 31, 2024April 30, 2024
Phone InterviewJanuary 9 - 10, 2024March 11-12, 2024May 27-28, 2024
Kick-off VenueTBD (In person)TBD (In person)TBD
Course Kick-offMarch 4-7, 2024May 6-9, 2024July 8-11, 2024
Webinars (Virtual)March 13, 20, 27
April 3, 10, 17, 2024
May 15, 22, 29
June 5, 12, 18, 2024
July 17, 24, 31
Aug 7, 14, 21, 2024
Close-out VenueBethesda MD, (In person)Bethesda MD, (In person)TBD
Course Close-outApril 22-23, 2024June 24-25, 2024Aug 26-27, 2024
Cohort Size24 Teams24 Teams8-16 Teams

Inquiries

Please direct all inquiries to:

Eric Padmore, MHSA
NIH Small Business Education and Entrepreneurial Development, (SEED)
Email: [email protected]